TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15514 · Feb 21

#dart#clash#clashmeta#ech#hysteria#hysteria2#proxy#reality#shadowsocks#shadowtls#sing_box#singbox#ssh#tuic#v2ray#vless#vmess#wireguard#xray Hiddify is a free, ad-free, open-source proxy VPN app for Android, iOS, Windows, macOS, and Linux. It uses Sing-box to support protocols like Vless, Reality, Hysteria, TUIC, WireGuard, and SSH, with auto node selection by delay, subscription updates, TUN mode, and traffic info. Download from app stores or GitHub. It benefits you by providing secure, fast, private internet access to bypass restrictions in places like Iran or China, ensuring unrestricted browsing without costs or ads. https://github.com/hiddify/hiddify-app

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment